National Cancer Registry

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

ATC	Name	B/G	Ingredients	Dosage	Form	Price
R01AD11	NASACORT AQ	B	Triamcinolone acetonide - 55mcg/dose	55mcg/dose	Spray, suspension	1,003,850 L.L
R01AD11	RINEX	G	Triamcinolone acetonide - 55mcg/actuation	55mcg/actuation	Spray, suspension	712,876 L.L
R01AD09	NASONEX	B	Mometasone furoate (monohydrate) - 50mcg/dose	0.05%	Spray, suspension	529,474 L.L
R01AD09	AVOCOM	G	Mometasone furoate - 0.05%	0.05%	Spray	419,279 L.L
R01AD09	METASONE	G	Mometasone furoate - 50mcg/actuation	50mcg/actuation	Spray	419,791 L.L
R01AD09	METASPRAY	G	Mometasone furoate (monohydrate) - 50mcg/dose	50mcg/dose	Spray, suspension	349,399 L.L
R01AD09	MOMETASONE BIOGARAN	G	Mometasone furoate (monohydrate) - 50mcg/dose	50mcg/dose	Spray, suspension	501,253 L.L
R01AD09	SINOCORT METERED DOSE	G	Mometasone furoate - 0.05%	0.05%	Spray, suspension	419,279 L.L
R01AD09	TABUNEX	G	Mometasone furoate - 0.05%	0.05%	Spray	419,279 L.L
R01AD08	OTRIALLERGY	B	Fluticasone propionate - 50mcg/actuation	50mcg/actuation	Spray, suspension	675,953 L.L
R01AD08	RINISONA	G	Fluticasone propionate - 50mcg/actuation	50mcg/dose	Spray, suspension	556,351 L.L
R01AD08	TICANASE	G	Fluticasone propionate - 50mcg/actuation	12g/Bottle	Spray, suspension	405,840 L.L
R01AC03	ALLERGODIL NASAL	B	Azelastine HCl - 0.14mg/dose	0.14mg/dose	Spray, solution	657,139 L.L
R01AB08	RINOFLUIMUCIL	B	Acetylcysteine - 1%, Tuaminoheptane sulfate - 0.5%, Benzalkonium chloride - 0.0125%		Solution	419,279 L.L
R01AB06	TRIOFAN	B	Xylometazoline HCl - 0.5mg/ml, Carbocysteine - 5mg/ml		Spray, solution	608,761 L.L
R01AB06	TRIOFAN	B	Xylometazoline HCl - 1mg/ml, Carbocysteine - 10mg/ml		Spray, solution	646,388 L.L
R01AB06	NARIX	G	Xylometazoline HCl - 90mcg/actuation, Carbocisteine - 900mcg/actuation		Spray	518,339 L.L
R01AB06	OTRIVIN DUAL RELIEF	B	Xylometazoline HCl - 0.5mg/ml, Ipratropium bromide - 0.6mg/ml		Solution	563,070 L.L
R01AB01	VAPICIL MICRODOSER	G	Phenylephrine - 2.5mg/ml, Dimethindene maleate - 0.25mg/ml		Spray	239,204 L.L
R01AA07	OTRIVIN	B	Xylometazoline HCl - 0.1%	0.1%	Solution	260,705 L.L
R01AA07	DECOZAL	G	Xylometazoline HCl - 0.1%	0.1%	Metered dose spray	147,823 L.L
R01AA07	DECOZAL	G	Xylometazoline HCl - 0.1%	0.1%	Drops	145,135 L.L
R01AA07	OTRIVIN	B	Xylometazoline HCl - 0.1%	0.1%	Drops	241,892 L.L
R01AA07	OTRIVIN MENTHOL 0.1%	B	Xylometazoline HCl - 0.1%	0.1%	Drops	387,027 L.L
R01AA07	OTRIVIN	B	Xylometazoline HCl - 0.05%	0.05%	Solution	260,705 L.L
R01AA07	DECOZAL	G	Xylometazoline HCl - 0.05%	0.05%	Metered dose spray	155,886 L.L
R01AA07	DECOZAL	G	Xylometazoline HCl - 0.05%	0.05%	Metered dose spray	108,851 L.L
R01AA07	OTRIVIN	B	Xylometazoline HCl - 0.05%	0.05%	Drops	181,419 L.L
R01AA07	XYLO-COMOD	G	Xylometazoline HCl - 0.1%	0.1%	Solution	499,909 L.L
R01AA05	UTABON	G	Oxymetazoline HCl - 0.5mg/ml	0.5mg/ml	Spray, solution	302,365 L.L

National Cancer Registry (NCR)